Wockhardt gets DGCI approval for 2 new antibiotics
"DCGI (Drug Controller General of India) has approved Wockhardt's two new antibiotics, EMROK (IV) and EMROK 0 (Oral), for acute bacterial skin and skin structure infections including diabetic foot infections and concurrent bacteraemia...," the drug firm said. The new drug will target superbug like Methicillin resistant Staphylococcus aureus. (Source: The Economic Times Healthcare and Biotech News)
Source: The Economic Times Healthcare and Biotech News - January 15, 2020 Category: Pharmaceuticals Source Type: news
NHS declares victory on MRSA and takes fight to E coli
Trusts and clinical commissioning groups face new annual targets designed to combat rising levels of four bloodstream infections, but sanctions relating to MRSA and C difficile could be scrapped. (Source: HSJ)
Source: HSJ - January 10, 2020 Category: UK Health Source Type: news
New Strategies to Prevent MRSA Infections in Your Hospital New Strategies to Prevent MRSA Infections in Your Hospital
A community hospital ' s rate of MRSA bloodstream infections is much higher than the national rate. Would you know what to do to reverse this trend?CDC Expert Commentary (Source: Medscape Infectious Diseases Headlines)
Source: Medscape Infectious Diseases Headlines - December 23, 2019 Category: Infectious Diseases Tags: Infectious Diseases Case Challenge Source Type: news
The new polymer can kill drug-resistant bacteria
Researchers from Singapore-MIT Alliance for Research and Technology (SMART), MIT's research enterprise in Singapore, and Nanyang Technological University (NTU) have designed an antimicrobial polymer that can kill bacteria resistant to commonly used antibiotics, including the superbug Methicillin-resistant Staphylococcus aureus (MRSA). (Source: World Pharma News)
Source: World Pharma News - December 12, 2019 Category: Pharmaceuticals Tags: Featured Research Research and Development Source Type: news
FDA Clears Faster Diagnostic Test for MRSA
(Source: eMedicineHealth.com)
Source: eMedicineHealth.com - December 6, 2019 Category: General Medicine Source Type: news
FDA Clears Faster Diagnostic Test for MRSA FDA Clears Faster Diagnostic Test for MRSA
The cobas vivoDx MRSA test uses a new bacteriophage technology based on bioluminescence to detect MRSA from nasal swab samples in 5 hours or less compared with 24 to 48 hours for conventional cultures.FDA Approvals (Source: Medscape Emergency Medicine Headlines)
Source: Medscape Emergency Medicine Headlines - December 6, 2019 Category: Emergency Medicine Tags: Infectious Diseases News Alert Source Type: news
Survey finds high level of self-prescribing among doctors
Young doctors also prescribing to friends and family Related items fromOnMedica GPs need more time to treat complex needs GPs defend practice on prescribing statins Double check patients with ‘penicillin’ allergy to avoid MRSA risk Clinicians need better options if we are to stop over-medication MHRA tightens licence restrictions on valproate for women (Source: OnMedica Latest News)
Source: OnMedica Latest News - December 3, 2019 Category: UK Health Source Type: news
MRSA Spreads Easily in Households MRSA Spreads Easily in Households
Methicillin-resistant Staphylococcus aureus (MRSA) can spread easily from people to household pets, according to a new study that underscores the importance of frequent handwashing.Reuters Health Information (Source: Medscape Pathology Headlines)
Source: Medscape Pathology Headlines - November 28, 2019 Category: Pathology Tags: Infectious Diseases News Source Type: news
Longitudinal, strain-specific Staphylococcus aureus introduction and transmission events in households of children with community-associated meticillin-resistant S aureus skin and soft tissue infection: a prospective cohort study
Review of 150 children with community-associated MRSA (caMRSA) skin and soft tissue infections found that sharing bedrooms, sharing bath towels and living in homes with a higher environmental contamination burden increased the likelihood of spread of caMRSA. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - November 28, 2019 Category: Consumer Health News Source Type: news
Household Environment Plays Role in MRSA Acquisition
WEDNESDAY, Nov. 27, 2019 -- The household environment plays a key role in the acquisition of methicillin-resistant Staphylococcus aureus (MRSA) skin and soft tissue infection, according to a study published online Nov. 26 in The Lancet Infectious... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - November 27, 2019 Category: Pharmaceuticals Source Type: news
Drug-resistant staph spreads easily in households
(Reuters Health) - The superbug MRSA (methicillin-resistant Staphylococcus aureus) can spread easily from people to household pets, according to a new study that underscores the importance of frequent handwashing. (Source: Reuters: Health)
Source: Reuters: Health - November 27, 2019 Category: Consumer Health News Tags: healthNews Source Type: news
This New Compound May Be Able To Battle A Common Hospital Superbug
Researchers in Canada have identified a new compound which makes superbug MRSA susceptible to treatment with common antibiotics again. (Source: Forbes.com Healthcare News)
Source: Forbes.com Healthcare News - November 26, 2019 Category: Pharmaceuticals Authors: Victoria Forster, Contributor Source Type: news
Potent antimicrobial found that shows promise in fighting staph infections
(McMaster University) After screening thousands of small molecules, the research team discovered a potent new antimicrobial they are calling MAC-545496 that is active against MRSA. Unlike conventional antibiotics, this new antimicrobial neither kills the staph infection nor halts its growth on its own, so the potential for antimicrobial resistance may be considerably lessened. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 25, 2019 Category: Infectious Diseases Source Type: news
Drug-resistant staph can spread easily in household environments
(Washington University in St. Louis) Once rare, the superbug methicillin-resistant Staphylococcus aureus (MRSA) infects hundreds of thousands of people in the US each year and kills about 20,000. New research led by Washington University School of Medicine in St. Louis sheds light on how MRSA is introduced into households and, once there, how it can spread among family members, including the furry ones. Understanding MRSA's transmission dynamics is critical to devising effective preventive tactics. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - November 21, 2019 Category: Infectious Diseases Source Type: news
A Tiny Bug Ended My NFL Career —and Almost My Life
During my nine years in the NFL, I ruptured tendons in my fingers, suffered multiple concussions, and broke several bones. I tore my ACL, MCL, and PCL, and completely blew out my left knee. That last injury should have ended my career. But it didn’t. I put myself back together and played through the pain.
What finally took me down? A tiny bug I had never heard of and couldn’t see. A drug-resistant staph infection called methicillin-resistant Staphylococcus aureus cost me my NFL career—and almost my life.
MRSA is one of many deadly, antibiotic-resistant infections. Together, these “superbugs” k...
Source: TIME: Health - November 19, 2019 Category: Consumer Health News Authors: Brandon Noble Tags: Uncategorized health Source Type: news
